Attovia Therapeutics, Inc. · NASDAQ:ATTO
Deep Track Capital, LP reported a 7.45% stake in Attovia Therapeutics, Inc. (Schedule 13G)
Event Aug 5, 2026 · Filed Aug 12, 2026
Deep Track Capital, LP reported a 7.45% stake in Attovia Therapeutics, Inc., 3,207,138 shares, as a passive investor on Aug 5, 2026. Filed Aug 12, 2026 (Schedule 13G).
- Stake
- 7.45%
- Shares
- 3,207,138
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deep Track Capital, LP | 7.45% | 3,207,138 |
| Deep Track Biotechnology Master Fund, Ltd. | 7.45% | 3,207,138 |
| David Kroin | 7.45% | 3,207,138 |
Source
Related
- Attovia Therapeutics, Inc.
- Deep Track Capital, LP
- Attovia Therapeutics, Inc. shareholders
- Form 4/A · Walsh Colin · Aug 28, 2026
- Form 4/A · Goldman Sachs Asset Management, L.P. · Aug 28, 2026
- Form 4 · Goldman Sachs & Co. LLC · Aug 13, 2026
- Schedule 13D · Frazier Life Sciences XI, L.P. · Aug 11, 2026
- Form 4 · venBio Global Strategic Fund IV, L.P. · Aug 10, 2026